Neuberger Berman Group LLC Grifols Sa Transaction History

Neuberger Berman Group LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 12, 2020	SELL	$19.57 - $23.52 $709,079 - $852,200	-36,233 Closed	0 $0
Q3 2019 Nov 13, 2019	SELL	$19.85 - $22.76 $76,144 - $87,307	-3,836 Reduced 9.57%	36,233 $726,000
Q2 2019 Aug 13, 2019	BUY	$17.59 - $21.1 $6,086 - $7,300	346 Added 0.87%	40,069 $845,000
Q1 2019 May 13, 2019	SELL	$18.01 - $20.11 $40,774 - $45,529	-2,264 Reduced 5.39%	39,723 $799,000
Q4 2018 Feb 12, 2019	SELL	$17.44 - $21.53 $55,284 - $68,250	-3,170 Reduced 7.02%	41,987 $771,000
Q3 2018 Nov 13, 2018	SELL	$19.97 - $21.96 $103,903 - $114,257	-5,203 Reduced 10.33%	45,157 $965,000
Q2 2018 Aug 13, 2018	SELL	$20.16 - $24.68 $5,160 - $6,318	-256 Reduced 0.51%	50,360 $1.08 Million
Q1 2018 May 08, 2018	SELL	$20.31 - $24.95 $487 - $598	-24 Reduced 0.05%	50,616 $1.07 Million
Q4 2017 Feb 14, 2018	BUY	$20.99 - $23.89 $29,868 - $33,995	1,423 Added 2.89%	50,640 $1.16 Million
Q3 2017 Nov 15, 2017	BUY	$20.07 - $21.89 $987,785 - $1.08 Million	49,217	49,217 $1.08 Million

164

140M

288K

389K

Ticker GRFS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 678,910,976
Market Cap $5.33B
Description
Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...

Get notified when there are updates to the investment portfolio of Neuberger Berman Group LLC, based on Form 13F filings with the SEC.

Stay updated on Neuberger Berman Group LLC with notifications on news.